Avai Bio (AVAI) Operating Income (2018 - 2026)

Avai Bio has disclosed Operating Income across 9 years of filings, most recently posting -$552041.0 for Q2 2026.

• In Q2 2026, Operating Income fell 213.22% year-over-year to -$552041.0; the TTM figure through Jun 2026 stood at -$1.8 million (down 53.03% YoY), while the FY2026 annual figure was -$1.7 million, down 53.18% from the prior year.
• Operating Income came in at -$552041.0 for Q2 2026 at Avai Bio, down from -$255177.0 in the prior quarter.
• In the past five years, Operating Income ranged from a high of $1.0 million in Q4 2023 to a low of -$4.0 million in Q1 2024.
• Average Operating Income over 5 years is -$333243.4, with a median of $18480.5 recorded in 2022.
• The largest YoY upside for Operating Income was 1282.71% in 2023 against a maximum downside of 8058.44% in 2023.
• Over 5 years, Operating Income stood at $110471.0 in 2022, then soared by 817.8% to $1.0 million in 2023, then slumped by 55.39% to $452298.0 in 2024, then slumped by 222.43% to -$553727.0 in 2025, then rose by 0.3% to -$552041.0 in 2026.
• Per Business Quant data, the three most recent Operating Income figures were -$552041.0 in Q2 2026, -$255177.0 in Q1 2026, and -$553727.0 in Q4 2025.